PR

Prakash Revinselvan

Active Director Director DIN 11067279
DIN 11067279 First appointment Apr 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Prakash Revinselvan

Data last updated:

Prakash Revinselvan is a Director at Navals Biotech Private Limited (since 2025). The company operates in Biotechnology.

DIN 11067279
Primary Designation Director
Industry Biotechnology
First Appointment 21 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Navals Biotech Private Limited U72100TN2025PTC179616
Director21 Apr 20252025Active

Board colleagues of Prakash Revinselvan

Directorship timeline

Open interactive timeline →
Navals Biotech Private Limited
Premium access

Shareholding and investment profile for Prakash Revinselvan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prakash Revinselvan

Prakash Revinselvan currently holds 1 directorship: Navals Biotech Private Limited (Director, since 21 Apr 2025).

Prakash Revinselvan was first appointed on 21 Apr 2025 as Director at Navals Biotech Private Limited.

The current boards of Prakash Revinselvan's companies include Nalli Selvarani (Navals Biotech Private Limited), Prakash Selvarani Priyadharshini (Navals Biotech Private Limited), Sellappa Gounder Kandasamy Prakash (Navals Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available